Table 2.
Pathway | Gene Name | Gestational Age | Case Status | ||||
---|---|---|---|---|---|---|---|
P Value | FDR Q Val | Effect Size per Week of Gestation | P Value | FDR Q Val | Fold Change (Up in Cases) | ||
Oxidative stress | NOS1b,c | .014 | .183 | ↓ 38% | .007 | .59 | 2.11 |
Oxidative stress | DDOb | .001 | .028 | ↓ 48% | .061 | .59 | 1.73 |
Inflammation | B2Mb | <.001 | .001 | ↓ 60% | .12 | .59 | 2.82 |
HPA axis | GRIA2b | .236 | .235 | ↓ 19% | .09 | .59 | 2.03 |
Abbreviations: B2M, beta-2 microglobulin; DDO, d-aspartate oxidase; FDR Q-val, false discovery rate–corrected Q value; GRIA2, glutamate ionotropic receptor AMPA type subunit 2; HPA, hypothalamic–pituitary–adrenal; NOS1, nitric oxide synthase 1; AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid.
aFour of 65 genes from various pathways were chosen to illustrate findings. Significance is defined as P < .05 with FDR Q-val of ≤0.10.
bGenes significantly negatively associated with gestational age at delivery.
cGenes significantly associated with case status.